selective estrogen receptor modulators การใช้

• Selective estrogen receptor modulators have varying effects on different isoforms of the estrogen receptor.
• Tamoxifen and raloxifene belong to a class of drugs called SERMS, for selective estrogen receptor modulators.
• It's the first drug known as selective estrogen receptor modulators ( SERMS ) approved for osteoporosis.
• Subtype selective estrogen receptor modulators preferentially bind to either the ?-or the ?-subtype of the receptor.
• Evista, known chemically as raloxifene, is part of a new class of drugs known as selective estrogen receptor modulators.
• The concept of selective estrogen receptor modulators is based on the ability to promote ER interactions with different proteins such as corepressors.
• Lilly is the first company to win approval of a drug in the class known as selective estrogen receptor modulators for osteoporosis prevention.
• The company and others developing drugs in the class known as selective estrogen receptor modulators are currently studying the drugs'anti-cancer effects.
• Tamoxifen, sold as Nolvadex, is the first of a new class of drugs called SERM's, for selective estrogen receptor modulators.
• Commonly used drugs are bisphosphonates including alendronate, risedronate, and ibandronate; selective estrogen receptor modulators ( SERMs ) such as raloxifene; estrogen; calcitonin; and teriparatide.
• They have fewer side effects than selective estrogen receptor modulators like tamoxifen, but do not work in premenopausal women, because they do not prevent the ovaries from producing estrogen.
• Selective estrogen receptor modulators, specifically tamoxifen, have been found to reduce breast cancer risk in women with " BRCA " mutations who do not have their breast removed.
• The new drugs, known as selective estrogen receptor modulators, are expected to revolutionize a market burgeoning as the baby boomers age and as more people become aware of the risks of osteoporosis.
• This story is told in : V . Craig Jordan, ed . 2013 . " Estrogen Action, Selective Estrogen Receptor Modulators and Women's Health " Imperial College Press, Singapore.
• Endocrine therapy for breast cancer involves selective estrogen receptor modulators ( SERMS ), such as tamoxifen, which behave as ER antagonists in breast tissue, or aromatase inhibitors, such as anastrozole.
• Designer estrogens, also called SERMs for Selective Estrogen Receptor Modulators, may cause future problems for the Initiative as well, depending on when such drugs become available and what claims are made for them.
• A variety of drug remedies currently used or proposed for osteoporosis may work for spaceflight, including hormone therapy ( estrogen and / or progestin ), selective estrogen receptor modulators, bisphosphonates, teriparatide, and others.
• In breast cancer survivors, it is recommended to first consider non-hormonal options for menopausal effects, such as bisphosphonates or selective estrogen receptor modulators ( SERMs ) for osteoporosis, and vaginal estrogen for local symptoms.
• "Selective estrogen receptor modulators " ( SERMs ) are an important class of hormonal therapy agents which act as antagonists of the estrogen receptor and are used primarily for the treatment and chemoprevention of breast cancer.
• Such conditions may be treated with drugs with antiestrogen actions, including selective estrogen receptor modulators ( SERMs ) such as tamoxifen and clomifene, estrogen receptor antagonists such as fulvestrant, aromatase inhibitors such as anastrozole and exemestane,